Scientists Develop ‘Highly Active Antiviral Drug’ Against HIV
The Russian Central Research Institute of Epidemiology has reportedly developed a new gene therapy medicine for people who have HIV.
Anna Popova, head of the federal health and epidemic watchdog Rospotrebnadzor, made this known on Wednesday.
“The Central Research Institute of Epidemiology of Rospotrebnadzor created a fundamentally new drug for gene therapy, gene prophylactic treatment and molecular vaccination against HIV,” Popova said on the sidelines of an international conference on HIV and AIDS in Moscow.
“A highly active antiviral drug called Dinavir, which will soon be clinically tested, has been created.”
The official noted that Russia was facing a number of problems related to treatment of HIV and AIDS, including high prices for treatment and lack of proper medication.